Shelly L. Sayre - Concepedia

Author

Shelly L. Sayre

The University of Texas Health Science Center at Houston

Also Known As

Sayre, Shelly L., Shelly L Sayre, Shelly L. Sayre, Shelly Sayre

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at Houston Minneapolis Heart Institute Foundation University of Florida University of Minnesota Abbott Northwestern Hospital

About

Shelly L. Sayre is an author at The University of Texas Health Science Center at Houston specializing in medicine, addiction, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	674
2	Public Health	6	6	199
3	Health Sciences	4	4	176
4	Behavioral Sciences	3	3	106
5	Social Sciences	2	2	123

Shelly L. Sayre

Publications

Citations

H-Index

Page 1

	Year	Citations
Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure Emerson C. Perin, James T. Willerson, Carl J. Pepine, JAMA	2012	454
Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction Jay H. Traverse, Timothy D. Henry, Carl J. Pepine, JAMA	2012	386
A Phase <scp>II</scp> study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the <scp>CCTRN CONCERT‐HF</scp> trial Roberto Bolli, Raul D. Mitrani, Joshua M. Hare, European Journal of Heart Failure	2021	158
Determining predictors of attrition in an outpatient substance abuse program Shelly L. Sayre, Joy M. Schmitz, Angela L. Stotts, The American Journal of Drug and Alcohol Abuse Family MedicineSubstance UseTreatment DropoutsMental HealthDrug Treatment	2002	105
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit <sup>+</sup> Cardiac Stem Cells As Regenerative Therapy for Heart Failure) Roberto Bolli, Joshua M. Hare, Keith L. March, Circulation Research	2018	100
Cognitive–Behavioral Treatment of Bipolar Disorder and Substance Abuse: A Preliminary Randomized Study Joy M. Schmitz, Patricia M. Averill, Shelly L. Sayre, Addictive Disorders & Their Treatment Psychiatric EvaluationMental HealthDrug TreatmentSubstance Use DisordersIndividual Cbt	2002	77
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction Jay H. Traverse, Timothy D. Henry, Douglas Vaughn, American Heart Journal ThrombosisCell TherapyBone Marrow FailureCardiovascular DiseasePlacebo-controlled Pilot Trial	2009	77
Detailed Analysis of Bone Marrow From Patients With Ischemic Heart Disease and Left Ventricular Dysfunction Christopher R. Cogle, Elizabeth Wise, Amy Meacham, Circulation Research	2014	66
Bone Marrow Characteristics Associated With Changes in Infarct Size After STEMI Robert C. Schutt, Barry Trachtenberg, John P. Cooke, Circulation Research	2014	59
LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. Jay H. Traverse, Timothy D. Henry, Douglas E. Vaughan, PubMed Cell TherapyHeart FailureCardiac RegenerationAcute Myocardial InfarctionCardiovascular Translational Research	2010	56

Page 1